88 related articles for article (PubMed ID: 8366615)
1. [Antiviral compounds: current approaches for development].
Suzutani T; Azuma M
Nihon Rinsho; 1993 Jul; 51(7):1907-14. PubMed ID: 8366615
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy of human immunodeficiency virus (HIV) infection: anti-HIV agents targeted at early stages in the virus replicative cycle.
De Clercq E
Biomed Pharmacother; 1996; 50(5):207-15. PubMed ID: 8949401
[TBL] [Abstract][Full Text] [Related]
3. Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA.
Chen H; Teng L; Li JN; Park R; Mold DE; Gnabre J; Hwu JR; Tseng WN; Huang RC
J Med Chem; 1998 Jul; 41(16):3001-7. PubMed ID: 9685239
[TBL] [Abstract][Full Text] [Related]
4. [A synthetic peptide "T22" as anti-HIV agents].
Nakashima H; Murakami T
Nihon Rinsho; 1993 Sep; 51 Suppl():146-52. PubMed ID: 8271378
[No Abstract] [Full Text] [Related]
5. Acyclovir blocks cytokine gene expression in trigeminal ganglia latently infected with herpes simplex virus type 1.
Halford WP; Gebhardt BM; Carr DJ
Virology; 1997 Nov; 238(1):53-63. PubMed ID: 9375008
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of glycoporphyrin derivatives and their antiviral activity against herpes simplex virus types 1 and 2.
Tomé JP; Neves MG; Tomé AC; Cavaleiro JA; Mendonça AF; Pegado IN; Duarte R; Valdeira ML
Bioorg Med Chem; 2005 Jun; 13(12):3878-88. PubMed ID: 15911304
[TBL] [Abstract][Full Text] [Related]
7. 1,2,4-Triazoloazine derivatives as a new type of herpes simplex virus inhibitors.
Deev SL; Yasko MV; Karpenko IL; Korovina AN; Khandazhinskaya AL; Andronova VL; Galegov GA; Shestakova TS; Ulomskii EN; Rusinov VL; Chupakhin ON; Kukhanova MK
Bioorg Chem; 2010 Dec; 38(6):265-70. PubMed ID: 20947122
[TBL] [Abstract][Full Text] [Related]
8. Simple synthesis of triester analogs of oligonucleotides for use as antisense antiviral agents.
Dyadchenko MA; Vinogradov SV
Nucleic Acids Symp Ser; 1991; (24):272. PubMed ID: 1668689
[No Abstract] [Full Text] [Related]
9. New anti-HSV therapeutics target the helicase-primase complex.
Crumpacker CS; Schaffer PA
Nat Med; 2002 Apr; 8(4):327-8. PubMed ID: 11927930
[No Abstract] [Full Text] [Related]
10. [Study of anti-HIV activity of azidothymidine and fluorothymidine 5'-phosphonates].
Mamaeva OA; Pliasunova OA; Pokrovskiĭ AG; Diatkina NB; Arzumanova AA
Mol Biol (Mosk); 1994; 28(1):137-42. PubMed ID: 8145741
[TBL] [Abstract][Full Text] [Related]
11. Quinoline-based compounds as modulators of HIV transcription through NF-kappaB and Sp1 inhibition.
Bedoya LM; Abad MJ; Calonge E; Saavedra LA; Gutierrez C M; Kouznetsov VV; Alcami J; Bermejo P
Antiviral Res; 2010 Sep; 87(3):338-44. PubMed ID: 20600334
[TBL] [Abstract][Full Text] [Related]
12. Bifunctional properties of analogues of modified nucleotides: immune system cells stimulation and human immunodeficiency virus (HIV) replication inhibition.
Pisarev VM; Tarussova NB; Leskov VP; Kremlev SG; Kuhanova MK; Tutelyan AV; Otrazheva ED; Pevnitzky LA
Nucleic Acids Symp Ser; 1991; (24):21. PubMed ID: 1841287
[No Abstract] [Full Text] [Related]
13. Polyanion inhibitors of HIV and other viruses. 7. Polyanionic compounds and polyzwitterionic compounds derived from cyclodextrins as inhibitors of HIV transmission.
Leydet A; Moullet C; Roque JP; Witvrouw M; Pannecouque C; Andrei G; Snoeck R; Neyts J; Schols D; De Clercq E
J Med Chem; 1998 Dec; 41(25):4927-32. PubMed ID: 9836609
[TBL] [Abstract][Full Text] [Related]
14. Antiviral susceptibility of Herpes simplex viruses and its clinical correlates: a single center's experience.
Rabella N; Otegui M; Labeaga R; Rodríguez P; Margall N; Gurguí M; Prats G
Clin Infect Dis; 2002 Apr; 34(8):1055-60. PubMed ID: 11914993
[TBL] [Abstract][Full Text] [Related]
15. Cell-dependent interference of a series of new 6-aminoquinolone derivatives with viral (HIV/CMV) transactivation.
Stevens M; Balzarini J; Tabarrini O; Andrei G; Snoeck R; Cecchetti V; Fravolini A; De Clercq E; Pannecouque C
J Antimicrob Chemother; 2005 Nov; 56(5):847-55. PubMed ID: 16150861
[TBL] [Abstract][Full Text] [Related]
16. Therapy of AIDS patients--classical strategies and proposals for novel therapeutic approaches (a short review).
Minárovits J; Berencsi G; Nász I; Földes I
Acta Microbiol Hung; 1988; 35(4):361-70. PubMed ID: 3072823
[No Abstract] [Full Text] [Related]
17. [Synthesis and antiherpes activity of acyclovir phosphoesters].
Galegov GA; Shobukhov VM; Leont'eva NA; Ias'ko MV
Bioorg Khim; 1997 Nov; 23(11):906-9. PubMed ID: 9518431
[TBL] [Abstract][Full Text] [Related]
18. [3'-Fluoro-deoxythymidine-5-fluorophosphate--an effective inhibitor of reproduction of human immunodeficiency virus in cell cultures].
Arzumanov AA; Diatkina NB; Kukhanova MK; Kraevskiĭ AA; Semchenko FM; Eremin OG; Martynov BI
Bioorg Khim; 1993 Oct; 19(10):978-80. PubMed ID: 8274172
[No Abstract] [Full Text] [Related]
19. [Clinical utility of susceptibility testing of herpes simplex virus to acyclovir].
Otegui M; Rabella N; Labeaga R; Herrero M; Margall N; Muñoz JM; Prats G
Rev Esp Quimioter; 2001 Dec; 14(4):351-7. PubMed ID: 11856981
[TBL] [Abstract][Full Text] [Related]
20. Early intervention with high-dose acyclovir treatment during primary herpes simplex virus infection reduces latency and subsequent reactivation in the nervous system in vivo.
Sawtell NM; Thompson RL; Stanberry LR; Bernstein DI
J Infect Dis; 2001 Oct; 184(8):964-71. PubMed ID: 11574910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
